LINC02736: A Potential Drug Target and Biomarker (G105369346)

Target Name: LINC02736

NCBI ID: G105369346

LINC02736

Other Name(s): long intergenic non-protein coding RNA 2736 | Long intergenic non-protein coding RNA 2736

LINC02736: A Potential Drug Target and Biomarker

LINC02736 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of the cell-cycle and is involved in the development, maintenance, and progression of cancer. LINC02736 has been shown to have tumor-suppressor properties and is currently being investigated as a potential drug target for various types of cancer.

The cell-cycle is the process by which cells grow, divide, and replicate their genetic material. The cell-cycle is regulated by a complex network of proteins that are involved in different stages of the cell cycle. One of the key proteins involved in the cell-cycle is the nuclear factor of activating T cells (NFAT), which is a transcription factor that regulates the expression of genes involved in the cell-cycle.

LINC02736 is a non-coding RNA molecule that is expressed in various tissues and cells and is involved in the regulation of the cell-cycle. It is a key regulator of the NFAT gene, which is involved in the development and maintenance of the cell-cycle. LINC02736 has been shown to play a critical role in the regulation of the NFAT gene and is involved in the development of cancer.

In addition to its role in the cell-cycle, LINC02736 has also been shown to have tumor-suppressor properties. Tumor suppressors are proteins that can inhibit the growth and spread of cancer cells. LINC02736 has been shown to have these properties by regulating the activity of the NFAT gene and by preventing the growth and spread of cancer cells.

LINC02736 has also been shown to be involved in the development and progression of various types of cancer. For example, studies have shown that LINC02736 is involved in the development of colon cancer and that it can be used as a potential drug target for this type of cancer. Additionally, LINC02736 has also been shown to be involved in the development and progression of breast cancer and that it can be used as a potential drug target for this type of cancer.

In conclusion, LINC02736 is a non-coding RNA molecule that is involved in the regulation of the cell-cycle and has been shown to have tumor-suppressor properties. It is currently being investigated as a potential drug target for various types of cancer, including colon cancer and breast cancer. Further research is needed to fully understand the role of LINC02736 as a drug target and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 2736

The "LINC02736 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02736 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets